Trupanion, Inc., a company operating within the financial sector, specializes in providing pet health insurance services. Based in Seattle, Washington, Trupanion offers medical insurance for dogs and cats, extending its services across Canada, Puerto Rico, and the United States. The company is publicly traded on the Nasdaq stock exchange and was established through an Initial Public Offering (IPO) on July 18, 2014.
As of the most recent trading day, January 20, 2026, Trupanion’s stock closed at $31.75. This price reflects a position within the stock’s 52-week range, which saw a high of $57.885 on June 26, 2025, and a low of $30.85 on January 19, 2026. The stock’s recent performance indicates moderate volatility, with prices fluctuating within a near-mid-range of its historical extremes.
Trupanion’s market capitalization stands at approximately $1.37 billion USD, underscoring its significant presence in the pet insurance industry. The company’s valuation metrics reveal a price-to-earnings (P/E) ratio of 19.99, suggesting that investors are willing to pay nearly 20 times the company’s earnings per share. Additionally, the price-to-book (P/B) ratio of 3.72 indicates that the stock is trading at a premium relative to its book value.
Despite the absence of new market commentary since the January 19, 2026 update, the stock maintains a hold stance from Stifel Nicolaus. This assessment suggests a neutral outlook, with no immediate recommendations for buying or selling the stock. Investors and stakeholders can find more information about Trupanion’s services and offerings on their official website, www.trupanion.com .
In summary, Trupanion, Inc. continues to be a notable player in the pet health insurance market, with a stable financial profile and a strategic presence across multiple regions. The company’s stock performance and valuation metrics reflect its established position and investor confidence in its business model.
